Stock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties

Stock Track

07/31

Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.

The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.

The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1126339393"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1126339393\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1126339393?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 03:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126339393","market":"sg","top_or_hot":-1,"title":"Stock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties","media":"Stock Track","content":"<p>Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.</p><p>The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.</p><p>The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tempus AI Soars 5.01% Intraday as Median Technologies Partnership with Canon Highlights AI Healthcare Ties\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-07-31 03:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.</p><p>The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.</p><p>The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"","article_id":"1126339393","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126339393","pubTimestamp":1785440424,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.The rally...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI"},"translate_title":"股票跟踪 | Median Technologies 与佳能的合作伙伴关系凸显人工智能医疗保健关系，腾邦人工智能盘中飙升 5.01%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1},"content_text":"Tempus AI (TEM) shares surged 5.01% during intraday trading on Thursday, as the medical AI company benefited from positive sentiment surrounding a new partnership in the diagnostic AI space.The rally was fueled by an announcement from Median Technologies, which revealed a global commercialization agreement with Canon Medical Systems’ Olea Medical unit for its eyonis LCS lung cancer screening software. The news highlighted Median’s multi-channel go-to-market strategy, which notably includes an earlier strategic tie-up with Tempus AI. Investors viewed the expanding ecosystem of AI-driven diagnostics as a strong validation of the sector, lifting shares of Tempus AI in sympathy with the broader industry momentum.The movement reflects growing confidence in collaborative efforts within the medical AI landscape, as companies like Tempus AI continue to form key alliances to advance precision medicine and diagnostics.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}